Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds

Daniil Z., Koutsokera A., Gourgoulianis K.

Source: Eur Respir J 2006; 27: 434
Journal Issue: February

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Daniil Z., Koutsokera A., Gourgoulianis K.. Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds. Eur Respir J 2006; 27: 434

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema
Source: ERJ Open Res, 7 (3) 00316-2021; 10.1183/23120541.00316-2021
Year: 2021



The impact of emphysema in pulmonary fibrosis
Source: Eur Respir Rev 2013; 22: 153-157
Year: 2013



Mechanisms of exercise limitation in patients with combined fibrosis and pulmonary emphysema
Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases
Year: 2017

Effects of oxygen inhalation during exercise in patients with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010

Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Source: Eur Respir J 2010; 35: 105-111
Year: 2010



Combined pulmonary fibrosis and emphysema: a high-pressure situation
Source: Eur Respir J 2010; 35: 9-11
Year: 2010


Clinical features of combined pulmonary fibrosis and emphysema
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010


Patients with idiopathic pulmonary fibrosis and chronic obstructive lung disease leak inhaled nanoparticles to the blood.
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019

Monocyte subpopulations, airway inflammation and lung function in patients with occupational chronic obstructive pulmonary disease from exposure to industrial aerosols containing nanoparticles
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020


Combined idiopathic pulmonary fibrosis and emphysema: functional characterization
Source: Eur Respir J 2004; 24: Suppl. 48, 283s
Year: 2004

Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2015 – IPF pathogenesis
Year: 2015



Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 359-365
Year: 2012



The effectiveness of pulmonary rehabilitation including occupational therapy in patients with chronic pulmonary emphysema
Source: Eur Respir J 2002; 20: Suppl. 38, 376s
Year: 2002

Autoimmunity profile in patients with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Source: Eur Respir J 2005; 26: 586-593
Year: 2005



Novel compounds for WNT/ß-catenin induced lung repair in chronic obstructive pulmonary disease
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018